All In Biotech

Drug Trial Radar · NCT05648591

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder

Last checked: Nov 20, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

May 24, 2023

Primary completion

Dec 31, 2028

Study completion Dec 31, 2028

Sponsor

Lead sponsor
Vanda PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Dec 13, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.

Conditions

  • Schizophrenia
  • Bipolar I Disorder

Interventions

  • IloperidoneDrug

    oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with treatment-emergent adverse events (TEAEs) in the treatment period.Time frame: 1 year

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Vanda Investigational Site

    Dothan, Alabama · Recruiting

  • Vanda Investigational Site

    Little Rock, Arkansas · Recruiting

  • Vanda Investigational Site

    Denver, Colorado · Recruiting

  • Vanda Investigational Site

    Atlanta, Georgia · Recruiting

  • Vanda Investigational Site

    Atlanta, Georgia · Recruiting

  • Vanda Investigational Site

    Decatur, Georgia · Recruiting

  • Vanda Investigational Site

    Kinston, North Carolina · Recruiting

  • Vanda Investigational Site

    Cincinnati, Ohio · Recruiting

  • Vanda Investigational Site

    Garfield Heights, Ohio · Recruiting

  • Vanda Investigational Site

    Westlake, Ohio · Recruiting

  • Vanda Investigational Site

    Everett, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.